Atopic Dermatitis
Conditions
Keywords
atopic dermatitis, insulin resistance
Brief summary
The aim of the study is to determine the relationship between insulin resistance and disease duration and severity of atopic dermatitis.
Detailed description
The aim of the study is to determine the relationship between insulin resistance and disease duration and severity of atopic dermatitis. EASI and SCORAD values and disease duration of atopic dermatitis patients are calculated during the examination. HOMA-IR blood test result is compared with the results.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Atopic dermatitis patients confirmed by a dermatologist
Exclusion criteria
* patients younger than 2 years * patients older than 80 years * Atopic dermatitis patients without HOMA-IR result
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HOMA-IR | 12 months | Patients' blood test show the result of fasting insulin (microU/L) x fasting glucose (mmol/L)/22.5 |
| SCORAD index | 12 months | Severity scoring of atopic dermatitis is calculated for each patient in the study. 6 intensity items (erythema, edema/papulation, oozing/crusts, excoriations, lichenification, dryness); 2 subjective symptoms(itch, sleeplessness); body surface area are studied. Max score is 103. |
| EASI index | 12 months | Eczema Area and Severity Index is calculated for each patient in the study. Body surface area, 4 intensity items(erythema, induration, excoriation, lichenification) are studied. Max score is 72. |
| Duration of the disease | 12 months | The time from the first onset of symptoms of the disease to the present. The relationship between insulin resistance and disease duration is examined |
Countries
Turkey (Türkiye)